| | | | | | | |
 | MODERNA, INC. | 0.90% | -9.72% | -2.09% | 3.68% | 762.90% | 66 963 |
| IQVIA HOLDINGS INC. | 2.69% | 3.09% | 17.02% | -5.77% | 54.44% | 43 368 |
 | LONZA GROUP AG | 4.91% | -0.19% | 20.64% | -14.62% | 37.51% | 42 273 |
| ALNYLAM PHARMACEUTICALS, INC. | 2.31% | -0.75% | -3.17% | 58.42% | 100.69% | 27 670 |
 | CELLTRION, INC. | 5.07% | 2.72% | 5.79% | 16.95% | 11.35% | 19 820 |
| ICON PUBLIC LIMITED COMPANY | 3.41% | 1.50% | 25.50% | -11.64% | 44.36% | 19 247 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD. | 1.52% | -5.49% | 12.66% | 14.33% | 61.17% | 14 661 |
| BIO-TECHNE CORPORATION | 3.69% | 1.82% | 1.69% | -19.32% | 62.66% | 12 758 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 3.95% | 3.03% | 18.41% | -24.79% | 66.14% | 12 629 |
| PHARMARON BEIJING CO., LTD. | -1.94% | -12.34% | 7.00% | -7.70% | 86.25% | 12 173 |
| UNITED THERAPEUTICS CORPORATION | -1.07% | -2.23% | -7.50% | 27.26% | 169.17% | 11 850 |
| QIAGEN N.V. | -0.26% | -2.14% | -1.12% | -1.24% | 46.84% | 11 257 |
 | GENSCRIPT BIOTECH CORPORATION | 1.06% | 1.81% | 14.69% | 16.09% | 55.40% | 7 607 |
| MEDPACE HOLDINGS, INC. | 3.24% | -0.33% | 10.61% | 31.91% | 168.33% | 7 059 |
| BACHEM HOLDING AG | -1.53% | -1.65% | 0.75% | -27.39% | 132.78% | 6 497 |
| | | | | | | |
| | Moyenne | 1.86% | -1.39% | 8.06% | 3.74% | 124.00% | |
| | Moyenne pondérée par Capi. | 2.27% | -2.16% | 8.24% | 3.62% | 213.67% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
